lawsuits news from FiercePharma
NewsGroup wants Ortho patch withdrawn
We've all heard the safety warnings about the Ortho-Evra birth control patch and its link to Read more...
Judge wary of certifying Zyprexa classes
Score one for Eli Lilly in federal court. A district judge says he probably won't give class-action status to patients and insurers who paid for Zyprexa for FDA-approved uses. And he doesn't expect Read more...
If J&J misled FDA, can patients sue?
Drug companies appear to be close to gaining a long-coveted prize: A shield against patient lawsuits. The Bush administration has been Read more...
AstraZeneca rivals could launch any day
You can bet the execs at AstraZeneca are biting their nails this week. Next Monday, April 14, marks the end of a 30-month stay on Ranbaxy Laboratories' copycat form of the mega-blockbuster Nexium. Read more...
Conn. sues FDA for OxyContin warnings
If your petition doesn't succeed, go to court. That's what Connecticut Attorney General Richard Blumenthal has done: He's sued the FDA to force the agency to act on his bid for tougher warnings on Read more...
Judge: FDA can't police drugs alone
As Eli Lilly went up to bat in the big Zyprexa trial in Alaska, Read more...
SPOTLIGHT: New bill would change law on device suits
Last month, the U.S. Supreme Court voted that patients can't sue device makers over products approved by the FDA. Now, a Congressman has introduced a bill that would change the law to make those Read more...
Courts more open to patent-busting
Patents aren't just an issue in Thailand, either. These days, drugmakers are having a more difficult time keeping patent protection on their products, the Financial Times notes. Ever since top U.S. Read more...
FDA: Epilepsy drugs boost suicial thoughts
The FDA issued a sobering warning yesterday: the risk of suicide and suicidal behavior doubles for patients taking epilepsy drugs. Millions are--they're prescribed not only for the seizure disorder Read more...
Shareholders sue Lilly over Zyprexa
As if patient lawsuits and government investigations weren't enough, now Eli Lilly shareholders are suing. The shareholders accuse Lilly execs and directors of blowing off the risks of pushing Read more...
| Press ReleasesPRESS RELEASE: Merck Agreement to Resolve U.S. VIOXX Product Liability Lawsuits Merck Agreement to Resolve U.S. VIOXX® Product Liability Lawsuits Agreement Provides for $4.85 Billion Payment WHITEHOUSE STATION, N.J., Nov. 9, 2007 - Merck & Co., Inc. today announced Read more... PRESS RELEASE: Wyeth Jury Awards $99 Million Punitive Damages Wyeth Jury Awards $99 Million Punitive Damages MADISON, N.J., Oct. 15 -- Wyeth confirmed today that it will appeal the verdict in the Scofield, Rowatt and Forrester v. Wyeth cases in the Second Read more... PRESS RLEASE: Repligen Announces Settlement with ImClone in Erbitux Lawsuit Repligen Announces Settlement with ImClone in Erbitux Lawsuit WALTHAM, MA - September 10, 2007 - Repligen Corporation announced today it has reached a settlement with ImClone Systems, Incorporated Read more... PRESS RELEASE: Genzyme Announces Settlement of Lawsuit Concerning Consolidation of Tracking StocksGenzyme Announces Settlement of Lawsuit Concerning Consolidation of Tracking Stocks Aug. 9 -- Genzyme Corp. today announced that it has reached an agreement in principle to settle a class action Read more... |
Get more lawsuits coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight